Find Grants for Higher Education

Find out if you qualify for verified grants for Higher Education. Discover your eligibility and key funding details for Higher Education from major foundations and government agencies.

$ 100 Trillion
Total Dollars Available

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-24-311

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.394, 93.395, 93.396

NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)

Deadline: November 12, 2027


Opportunity Number: PAR-24-321

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: November 12, 2027

Status: Posted

CFDA Numbers: 93.866

Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-227

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Deadline: January 7, 2027


Opportunity Number: PAR-25-221

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.396, 93.273

Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2026


Opportunity Number: PAR-24-306

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.393, 93.395, 93.396, 93.394

Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

Deadline: January 6, 2028


Opportunity Number: PAS-25-205

Agency: National Institutes of Health

Open Date: November 6, 2024

Close Date: January 6, 2028

Status: Posted

CFDA Numbers: 93.839, 93.847, 93.866

BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)

Deadline: September 28, 2026


Opportunity Number: RFA-NS-25-021

Agency: National Institutes of Health

Open Date: November 5, 2024

Close Date: September 28, 2026

Status: Posted

CFDA Numbers: 93.866, 93.867, 93.242, 93.213, 93.865, 93.173, 93.853, 93.286, 93.273, 93.279

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)

Deadline: September 28, 2026


Opportunity Number: RFA-NS-25-022

Agency: National Institutes of Health

Open Date: November 5, 2024

Close Date: September 28, 2026

Status: Posted

CFDA Numbers: 93.866, 93.867, 93.286, 93.279, 93.865, 93.853, 93.273, 93.173, 93.213, 93.242

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Deadline: October 25, 2027


Opportunity Number: PAR-25-104

Agency: National Institutes of Health

Open Date: November 5, 2024

Close Date: October 25, 2027

Status: Posted

CFDA Numbers: 93.399

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Deadline: October 25, 2027


Opportunity Number: PAR-25-103

Agency: National Institutes of Health

Open Date: November 5, 2024

Close Date: October 25, 2027

Status: Posted

CFDA Numbers: 93.399

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

Deadline: October 20, 2027


Opportunity Number: PAR-25-225

Agency: National Institutes of Health

Open Date: November 4, 2024

Close Date: October 20, 2027

Status: Posted

CFDA Numbers: 93.853

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)

Deadline: October 16, 2026


Opportunity Number: PAR-25-077

Agency: National Institutes of Health

Open Date: November 1, 2024

Close Date: October 16, 2026

Status: Posted

CFDA Numbers: 93.853, 93.855

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-143

Agency: National Institutes of Health

Open Date: October 31, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.279, 93.242, 93.273, 93.989, 93.307, 93.172, 93.866, 93.399, 93.846, 93.361, 93.173, 93.121, 93.113, 93.855, 93.865, 93.213, 93.853, 93.310

Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)

Deadline: January 7, 2028


Opportunity Number: PAR-25-207

Agency: National Institutes of Health

Open Date: October 31, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)

Deadline: June 2, 2027


Opportunity Number: PAR-25-210

Agency: National Institutes of Health

Open Date: October 31, 2024

Close Date: June 2, 2027

Status: Posted

CFDA Numbers: 93.866, 93.313, 93.393, 93.213, 93.121

Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

Deadline: June 2, 2027


Opportunity Number: PAR-25-211

Agency: National Institutes of Health

Open Date: October 31, 2024

Close Date: June 2, 2027

Status: Posted

CFDA Numbers: 93.393, 93.121, 93.213, 93.313, 93.866

Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)

Deadline: January 7, 2028


Opportunity Number: PAR-25-206

Agency: National Institutes of Health

Open Date: October 31, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)

Deadline: January 27, 2027


Opportunity Number: PAR-24-268

Agency: National Institutes of Health

Open Date: October 30, 2024

Close Date: January 27, 2027

Status: Posted

CFDA Numbers: 93.121, 93.242, 93.866, 93.273, 93.859, 93.853, 93.213, 93.867, 93.279, 93.310, 93.846

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-233

Agency: National Institutes of Health

Open Date: October 30, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.399, 93.242, 93.121, 93.279, 93.310, 93.113, 93.853, 93.172, 93.989, 93.273, 93.865, 93.866

Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)

Deadline: July 14, 2026


Opportunity Number: PAR-24-313

Agency: National Institutes of Health

Open Date: October 30, 2024

Close Date: July 14, 2026

Status: Posted

CFDA Numbers: 93.213

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-185

Agency: National Institutes of Health

Open Date: October 30, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865, 93.121, 93.351

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)

Deadline: July 14, 2026


Opportunity Number: PAR-24-312

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: July 14, 2026

Status: Posted

CFDA Numbers: 93.213

Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)

Deadline: April 15, 2027


Opportunity Number: PAR-25-131

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: April 15, 2027

Status: Posted

CFDA Numbers: 93.879

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-144

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.279, 93.242, 93.273, 93.866, 93.847, 93.307, 93.172, 93.846, 93.399, 93.853, 93.837, 93.361, 93.867, 93.855, 93.213, 93.121, 93.865, 93.113, 93.839, 93.840, 93.233, 93.838, 93.310

High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)

Deadline: June 1, 2027


Opportunity Number: PAR-24-264

Agency: National Institutes of Health

Open Date: October 29, 2024

Close Date: June 1, 2027

Status: Posted

CFDA Numbers: 93.351, 93.859, 93.286

×

Request Grant Writing Assistance from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.